Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Marcocci

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Orphanet Journal of Rare Diseases|October 10, 2021
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational studyGemma Marcucci, Paola Altieri, Salvatore Benvenga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2022
Management of Primary HyperparathyroidismJohn P Bilezikian, Shonni J Silverberg, Francisco Bandeira, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2018
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trialGeorge J Kahaly, Michaela Riedl, Jochem König, et al.
The British Journal of Ophthalmology|October 13, 2006
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyDavid McKeag, Carol Lane, John H Lazarus, et al.
Journal of the Endocrine Society|August 2, 2021
Management of Thyrotoxicosis Induced by PD1 or PD-L1 BlockadeAlessandro Brancatella, Isabella Lupi, Lucia Montanelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohortsLeonardo D'Agruma, Michela Coco, Vito Guarnieri, et al.
JBMR Plus|December 23, 2020
Controversies in Vitamin D: A Statement From the Third International ConferenceAndrea Giustina, Roger Bouillon, Neil Binkley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2008
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type IAntonella Meloni, Maria Furcas, Filomena Cetani, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2014
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPROTorquil Watt, Giuseppe Barbesino, Jakob Bue Bjorner, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Orphanet Journal of Rare Diseases|October 10, 2021
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational studyGemma Marcucci, Paola Altieri, Salvatore Benvenga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2022
Management of Primary HyperparathyroidismJohn P Bilezikian, Shonni J Silverberg, Francisco Bandeira, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2018
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trialGeorge J Kahaly, Michaela Riedl, Jochem König, et al.
The British Journal of Ophthalmology|October 13, 2006
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyDavid McKeag, Carol Lane, John H Lazarus, et al.
Journal of the Endocrine Society|August 2, 2021
Management of Thyrotoxicosis Induced by PD1 or PD-L1 BlockadeAlessandro Brancatella, Isabella Lupi, Lucia Montanelli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohortsLeonardo D'Agruma, Michela Coco, Vito Guarnieri, et al.
JBMR Plus|December 23, 2020
Controversies in Vitamin D: A Statement From the Third International ConferenceAndrea Giustina, Roger Bouillon, Neil Binkley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2008
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type IAntonella Meloni, Maria Furcas, Filomena Cetani, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2014
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPROTorquil Watt, Giuseppe Barbesino, Jakob Bue Bjorner, et al.
Pageof 21